AAAAAA

   
Results: 1-11 |
Results: 11
SAFETY, TOLERABILITY, AND PHARMACOKINETICS OF SUMATRIPTAN SUPPOSITORIES FOLLOWING SINGLE AND MULTIPLE DOSES IN HEALTHY-VOLUNTEERS
Authors: KUNKA RL HUSSEY EK SHAW S WARNER P AUBERT B RICHARD I FOWLER PA PAKES GE
Citation: Rl. Kunka et al., SAFETY, TOLERABILITY, AND PHARMACOKINETICS OF SUMATRIPTAN SUPPOSITORIES FOLLOWING SINGLE AND MULTIPLE DOSES IN HEALTHY-VOLUNTEERS, Cephalalgia, 17(4), 1997, pp. 532-540
SAFETY, TOLERABILITY, AND PHARMACOKINETICS OF SUMATRIPTAN IN HEALTHY-SUBJECTS FOLLOWING ASCENDING SINGLE INTRANASAL DOSES AND MULTIPLE INTRANASAL DOSES
Authors: MOORE KHP HUSSEY EK SHAW S FUSEAU E DUQUESNOY C PAKES GE
Citation: Khp. Moore et al., SAFETY, TOLERABILITY, AND PHARMACOKINETICS OF SUMATRIPTAN IN HEALTHY-SUBJECTS FOLLOWING ASCENDING SINGLE INTRANASAL DOSES AND MULTIPLE INTRANASAL DOSES, Cephalalgia, 17(4), 1997, pp. 541-550
EFFECTS OF THE NEURAMINIDASE INHIBITOR ZANAMIVIR ON OTOLOGIC MANIFESTATIONS OF EXPERIMENTAL HUMAN INFLUENZA
Authors: WALKER JB HUSSEY EK TREANOR JJ MONTALVO A HAYDEN FG
Citation: Jb. Walker et al., EFFECTS OF THE NEURAMINIDASE INHIBITOR ZANAMIVIR ON OTOLOGIC MANIFESTATIONS OF EXPERIMENTAL HUMAN INFLUENZA, The Journal of infectious diseases, 176(6), 1997, pp. 1417-1422
EFFECT OF ENZYME INDUCERS ON ONDANSETRON (OND) METABOLISM IN HUMANS
Authors: BRITTO MR HUSSEY EK MYDLOW P POWELL JR BROUWER KLR
Citation: Mr. Britto et al., EFFECT OF ENZYME INDUCERS ON ONDANSETRON (OND) METABOLISM IN HUMANS, Clinical pharmacology and therapeutics, 61(2), 1997, pp. 29-29
SAFETY AND EFFICACY OF THE NEURAMINIDASE INHIBITOR GG167 IN EXPERIMENTAL HUMAN INFLUENZA
Authors: HAYDEN FG TREANOR JJ BETTS RF LOBO M ESINHART JD HUSSEY EK
Citation: Fg. Hayden et al., SAFETY AND EFFICACY OF THE NEURAMINIDASE INHIBITOR GG167 IN EXPERIMENTAL HUMAN INFLUENZA, JAMA, the journal of the American Medical Association, 275(4), 1996, pp. 295-299
PHARMACOKINETICS OF LAMIVUDINE ADMINISTERED ALONE AND WITH TRIMETHOPRIMSULFAMETHOXAZOLE
Authors: MOORE KHP YUEN GJ RAASCH RH ERON JJ MARTIN D MYDLOW PK HUSSEY EK
Citation: Khp. Moore et al., PHARMACOKINETICS OF LAMIVUDINE ADMINISTERED ALONE AND WITH TRIMETHOPRIMSULFAMETHOXAZOLE, Clinical pharmacology and therapeutics, 59(5), 1996, pp. 550-558
SUMATRIPTAN ABSORPTION FROM DIFFERENT REGIONS OF THE HUMAN GASTROINTESTINAL-TRACT
Authors: WARNER PE BROUWER KLR HUSSEY EK DUKES GE HEIZER WD DONN KH DAVIS IM POWELL JR
Citation: Pe. Warner et al., SUMATRIPTAN ABSORPTION FROM DIFFERENT REGIONS OF THE HUMAN GASTROINTESTINAL-TRACT, Pharmaceutical research, 12(1), 1995, pp. 138-143
PHARMACOKINETICS, ABSOLUTE BIOAVAILABILITY, AND ABSORPTION CHARACTERISTICS OF LAMIVUDINE
Authors: YUEN GJ MORRIS DM MYDLOW PK HAIDAR S HALL ST HUSSEY EK
Citation: Gj. Yuen et al., PHARMACOKINETICS, ABSOLUTE BIOAVAILABILITY, AND ABSORPTION CHARACTERISTICS OF LAMIVUDINE, Journal of clinical pharmacology, 35(12), 1995, pp. 1174-1180
SINGLE-DOSE PHARMACOKINETICS OF SUMATRIPTAN IN HEALTHY-VOLUNTEERS
Authors: LACEY LF HUSSEY EK FOWLER PA
Citation: Lf. Lacey et al., SINGLE-DOSE PHARMACOKINETICS OF SUMATRIPTAN IN HEALTHY-VOLUNTEERS, European Journal of Clinical Pharmacology, 47(6), 1995, pp. 543-548
INTERSPECIES SCALING AND PHARMACOKINETIC PARAMETERS OF 3TC IN HUMANS
Authors: HUSSEY EK DONN KH DANIEL MJ HALL ST HARKER AJ EVANS GL
Citation: Ek. Hussey et al., INTERSPECIES SCALING AND PHARMACOKINETIC PARAMETERS OF 3TC IN HUMANS, Journal of clinical pharmacology, 34(10), 1994, pp. 975-977
PHARMACOKINETICS OF 3TC (GR109714X) ADMINISTERED WITH AND WITHOUT FOOD TO HIV-INFECTED PATIENTS
Authors: ANGEL JB HUSSEY EK HALL ST DONN KH MORRIS DM MCCORMACK JP MONTANER JSG RUEDY J
Citation: Jb. Angel et al., PHARMACOKINETICS OF 3TC (GR109714X) ADMINISTERED WITH AND WITHOUT FOOD TO HIV-INFECTED PATIENTS, Drug investigation, 6(2), 1993, pp. 70-74
Risultati: 1-11 |